open menu
About us
Innovation
Quality & compliance
Sustainability
News
Careers
Investors
Buy from VWR
Home
Newsroom
Home
/
Newsroom
/
Press Releases
Press Releases
In the News
Media Resources
Investor Relations
Press Releases
Month Year
Su
Mo
Tu
We
Th
Fr
Sa
25
26
27
28
29
30
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
1
2
3
4
5
Cancel
Go
Month Year
Su
Mo
Tu
We
Th
Fr
Sa
25
26
27
28
29
30
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
1
2
3
4
5
Cancel
Go
Year
All Years
2024
2023
2022
2021
2020
2019
Category
All Categories
CORPORATE
BIOPHARMA
RESEARCH
SUSTAINABILITY
Uncategorized
Keywords
Go
Advanced Search
Search
Search Headlines Only
Category
All Categories
CORPORATE
BIOPHARMA
RESEARCH
SUSTAINABILITY
Uncategorized
From
To
Asset Types
Video
Audio
Photos
Documents
Events
Standard
Mar 23, 2020
Avantor® Appoints Tommy Thomas as Vice President, Investor Relations
CORPORATE
Mar 18, 2020
Avantor® Launches New Protein A Chromatography Resin - PROchievA - that Provides Supply Chain Flexibility and Improves Downstream Purification Performance for Monoclonal Antibodies (mAbs) Production
BIOPHARMA
New high purity resin advances bioprocessing and brings choice and efficiencies to mAbs production workflow processes and protocols
Feb 18, 2020
Avantor® to Participate in Cowen and Company's 40th Annual Health Care Conference
CORPORATE
Feb 7, 2020
Avantor Reports Fourth Quarter and Full-Year 2019 Results
CORPORATE
- Net sales $1.52 billion, net income $70.6 million, adjusted EBITDA $263.6 million
Jan 24, 2020
Avantor® to Report Fourth Quarter and Full Year 2019 Earnings and Host Earnings Call on Friday, February 7
CORPORATE
Show
5
10
25
50
100
per page
«
1
…
33
34
35
36
37
38
39
40
41
»